Healthcare-focused VC TKS I leads $3m funding in CRO ObvioHealth

Contract research organisation ObvioHealth Inc has announced a $3 million series A financing round led by TKS I, a Singapore-based venture fund focused on lifesciences and healthcare.

Continue reading this story with a subscription to DealStreetAsia.


Contact us for corporate subscriptions at